Carmen Griñán-Lisón

13PUBLICATIONS
47CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 27, 2025
Modulation of Human Immune Cells by Propyl-Propane Thiosulfonate (PTSO) Inhibits Colorectal Tumor Progression in a Humanized Mouse Model.

María Jesús Rodríguez-Sojo, Luckman Gbati, Jose Alberto Molina-Tijeras

|Apr 17, 2025
Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem Cells.

Grazia Fenu, Carmen Griñán-Lisón, Federica Etzi

|Feb 26, 2025
Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy.

Violeta Delgado-Almenta, Jose L Blaya-Cánovas, Jesús Calahorra

|Jan 08, 2025
The Role of miR-486-5p on CSCs Phenotypes in Colorectal Cancer.

Federica Etzi, Carmen Griñán-Lisón, Grazia Fenu

|Jul 29, 2023
Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma.

María Belén García-Ortega, Ernesto Aparicio, Carmen Griñán-Lisón

|Jun 10, 2022
Caffeine and Chlorogenic Acid Combination Attenuate Early-Stage Chemically Induced Colon Carcinogenesis in Mice: Involvement of oncomiR miR-21a-5p.

Ariane Rocha Bartolomeu, Guilherme Ribeiro Romualdo, Carmen Griñán Lisón

Pageof 3